<p><i>Background/aims:</i> Acute aortic dissection (AAD) is a rare life-threatening disease that does not easily lend itself to randomized controlled trials. Data regarding the effect of treatment advances in the recent decades is limited. Determinants of follow-up mortality are poorly understood. To include many patients and evaluate contemporary management of AAD, the International Registry ...